About this episode
On this episode of the a16z Bio Clubhouse Show, a16z general partners Vineeta Agarwala and Vijay Pande talk to guest Ben Oakes, cofounder, President and CEO of Scribe Therapeutics. The conversation covers the the power of engineering gene editors, the transition from academia to a startup, and how to select the first indication to target with a novel bio platform.
Get every episode summarized
Each time a16z Live publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from a16z Live
How Startups are Fixing Healthcare Friction
a16z Live
Jun 25, 202523:54pending
What Comes After Mobile? Meta’s Andrew Bosworth on AI and Consumer Tech
a16z Live
Apr 24, 202532:30pending
Who Will Own the Internet? a16z’s Chris Dixon on AI and Crypto
a16z Live
Feb 21, 202532:55pending
How AI Is Changing Warfare, with Anduril CEO Brian Schimpf
a16z Live
Feb 13, 202535:22pending